A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported. Various case reports concerning dapsone-induced agranulocytosis are reviewed.
Bhat
Ramesh M
RM
Department of Dermatology, Venereology & Leprosy, Fr. Muller Medical College, Kankanady, Mangalore, Karnataka 575 002, India. rameshderma@yahoo.com
Radhakrishnan
K
K
D000380:Agranulocytosis / Q000139:chemically induced*; D003622:Dapsone / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D015439:Leprosy, Borderline / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D003622:Dapsone